Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belviq XR for Weight Loss in Obese Adolescents
NCT03338296Phase 4Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lorcaserin in obesity, sponsored by Eisai Co., Ltd.. Started Sep 2017; status: terminated.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03338296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338296.